Molecular Partners (MOLN) Total Assets by Year
Molecular Partners AG closed fiscal year 2025 with $128.7M in total assets, $27.4M in total liabilities and $101.2M in shareholder equity. Total assets fell 26.4% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Molecular Partners AG has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MOLN Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F |
|---|---|---|---|---|---|---|---|
| Total Assets | $128.7M-26.4% | $174.8M-25.9% | $236.0M-16.8% | $283.8M+50.3% | $188.8M-11.0% | $212.1M | N/A |
| Total Liabilities | $27.4M+47.3% | $18.6M-28.6% | $26.1M-11.0% | $29.3M-59.0% | $71.5M-21.3% | $90.9M | N/A |
| Total Equity | $101.2M-35.2% | $156.2M-25.6% | $209.9M-17.5% | $254.5M+116.9% | $117.3M-3.3% | $121.3M+116.8% | $55.9M |
MOLN Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q2'256-K | Q4'2420-F | Q2'246-K | Q4'2320-F | Q2'236-K | Q4'2220-F | Q2'226-K | Q4'2120-F | Q4'2020-F |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $128.7M-26.4% | $156.5M-17.5% | $174.8M-25.9% | $189.7M-26.3% | $236.0M-16.8% | $257.6M-17.8% | $283.8M+50.3% | $313.4M | $188.8M-11.0% | $212.1M |
| Total Liabilities | $27.4M+47.3% | $22.2M+32.4% | $18.6M-28.6% | $16.7M-38.9% | $26.1M-11.0% | $27.4M-21.7% | $29.3M-59.0% | $35.0M | $71.5M-21.3% | $90.9M |
| Total Equity | $101.2M-35.2% | $134.4M-22.3% | $156.2M-25.6% | $173.0M-24.9% | $209.9M-17.5% | $230.2M-17.3% | $254.5M+116.9% | $278.4M | $117.3M-3.3% | $121.3M |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Molecular Partners AG financials
Frequently Asked Questions
Molecular Partners AG closed fiscal year 2025 with $128.7M in total assets, $27.4M in total liabilities and $101.2M in shareholder equity.
Molecular Partners AG (MOLN) total assets fell by 26.4% year over year, from $174.8M to $128.7M in fiscal year 2025.
Molecular Partners AG (MOLN) reported $128.7M in total assets in Q4 2025. This represents a decrease of 26.4% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Molecular Partners AG (MOLN) reported on that line in every period on record.